Latest Breaking News On - Ys biopharma company profile - Page 1 : comparemela.com

Short Interest in YS Biopharma Co , Ltd (NASDAQ:YSBPW) Increases By 110 5%

Short Interest in YS Biopharma Co , Ltd (NASDAQ:YSBPW) Increases By 110 5%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Ys biopharma company profileYs biopharma co ltdGet free report

YS Biopharma (NASDAQ:YS) Trading Down 3 4%

YS Biopharma Co., Ltd. (NASDAQ:YS – Get Free Report) shares were down 3.4% during mid-day trading on Friday . The company traded as low as $0.39 and last traded at $0.40. Approximately 99,903 shares were traded during trading, a decline of 41% from the average daily volume of 168,291 shares. The stock had previously closed […]

Topco ltdBarclays plcYs biopharma company profileYs biopharma co ltdPrelude capital managementGet free reportNoble financialCapital managementYs biopharmaNasdaq ys

YS Biopharma Co , Ltd (NASDAQ:YS) Short Interest Update

YS Biopharma Co , Ltd (NASDAQ:YS) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Ys biopharma company profileHhlr advisorsTopco ltdPrelude capital managementYs biopharma co ltdBarclays plcGet free reportCapital managementNoble financial

Noble Financial Begins Coverage on YS Biopharma (NASDAQ:YS)

Noble Financial assumed coverage on shares of YS Biopharma (NASDAQ:YS – Free Report) in a research report released on Monday morning, Benzinga reports. The brokerage issued an outperform rating and a $5.25 price target on the stock. YS Biopharma Stock Down 1.4 % NASDAQ YS opened at $0.65 on Monday. The company has a current […]

Topco ltdYs biopharma company profileBarclays plcPrelude capital managementHhlr advisorsYs biopharma co ltdNoble financialFree reportStock downGet free reportCapital managementYs biopharmaNasdaq ysInitiated coverage

751,790 Shares in YS Biopharma Co , Ltd (NASDAQ:YS) Purchased by Hhlr Advisors LTD

Hhlr Advisors LTD. purchased a new position in YS Biopharma Co., Ltd. (NASDAQ:YS – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 751,790 shares of the company’s stock, valued at approximately $1,203,000. Hhlr Advisors LTD. owned approximately 2.92% of YS Biopharma at the […]

Ys biopharma company profileYs biopharma co ltdHhlr advisorsValliance asset management ltdFree reportAsset management ltdStock downGet free reportVisit holdingschannelYs biopharmaNasdaq ysSec filingsHedge fund holdingsInstitutional investor holdings